47 related articles for article (PubMed ID: 25877844)
1. HLA DR and DQ alleles and haplotypes associated with clinical response to glatiramer acetate in multiple sclerosis.
Dhib-Jalbut S; Valenzuela RM; Ito K; Kaufman M; Ann Picone M; Buyske S
Mult Scler Relat Disord; 2013 Oct; 2(4):340-8. PubMed ID: 25877844
[TBL] [Abstract][Full Text] [Related]
2. Multiple sclerosis is associated with genes within or close to the HLA-DR-DQ subregion on a normal DR15,DQ6,Dw2 haplotype.
Hillert J; Olerup O
Neurology; 1993 Jan; 43(1):163-8. PubMed ID: 8093808
[TBL] [Abstract][Full Text] [Related]
3. HLA and prognosis in multiple sclerosis.
Runmarker B; Martinsson T; Wahlström J; Andersen O
J Neurol; 1994 May; 241(6):385-90. PubMed ID: 7931434
[TBL] [Abstract][Full Text] [Related]
4. Major histocompatibility complex class II alleles and the course and outcome of MS: a population-based study.
Weinshenker BG; Santrach P; Bissonet AS; McDonnell SK; Schaid D; Moore SB; Rodriguez M
Neurology; 1998 Sep; 51(3):742-7. PubMed ID: 9748020
[TBL] [Abstract][Full Text] [Related]
5. Association of the HLA-DR15/HLA-DQ6 haplotype with development of choroidal neovascular lesions in presumed ocular histoplasmosis syndrome.
Dabil H; Kaplan HJ; Duffy BF; Phelan DL; Mohanakumar T; Jaramillo A
Hum Immunol; 2003 Oct; 64(10):960-4. PubMed ID: 14522093
[TBL] [Abstract][Full Text] [Related]
6. [Gluten enteropathy in Croatian children is primarily associated with the HLA-DR3-DQ2 haplotype].
Jurcić Z; Brkljacić-Surkalović L; Grubić Z; Zunec R; Vezmar V; Kastelan A
Lijec Vjesn; 2000; 122(11-12):259-63. PubMed ID: 11291267
[TBL] [Abstract][Full Text] [Related]
7. HLA-DR15 is associated with lower age at onset in multiple sclerosis.
Masterman T; Ligers A; Olsson T; Andersson M; Olerup O; Hillert J
Ann Neurol; 2000 Aug; 48(2):211-9. PubMed ID: 10939572
[TBL] [Abstract][Full Text] [Related]
8. HLA-DR predicts the prognosis in Scandinavian patients with pulmonary sarcoidosis.
Berlin M; Fogdell-Hahn A; Olerup O; Eklund A; Grunewald J
Am J Respir Crit Care Med; 1997 Nov; 156(5):1601-5. PubMed ID: 9372682
[TBL] [Abstract][Full Text] [Related]
9. HLA-DRB1*1501, -DQB1*0301, -DQB1*0302, -DQB1*0602, and -DQB1*0603 alleles are associated with more severe disease outcome on MRI in patients with multiple sclerosis.
Zivadinov R; Uxa L; Bratina A; Bosco A; Srinivasaraghavan B; Minagar A; Ukmar M; Benedetto Sy; Zorzon M
Int Rev Neurobiol; 2007; 79():521-35. PubMed ID: 17531857
[TBL] [Abstract][Full Text] [Related]
10. MHC Class II alleles in ulcerative colitis-associated colorectal cancer.
Garrity-Park MM; Loftus EV; Sandborn WJ; Bryant SC; Smyrk TC
Gut; 2009 Sep; 58(9):1226-33. PubMed ID: 19251712
[TBL] [Abstract][Full Text] [Related]
11. Genes in the HLA class I region may contribute to the HLA class II-associated genetic susceptibility to multiple sclerosis.
Harbo HF; Lie BA; Sawcer S; Celius EG; Dai KZ; Oturai A; Hillert J; Lorentzen AR; Laaksonen M; Myhr KM; Ryder LP; Fredrikson S; Nyland H; Sørensen PS; Sandberg-Wollheim M; Andersen O; Svejgaard A; Edland A; Mellgren SI; Compston A; Vartdal F; Spurkland A
Tissue Antigens; 2004 Mar; 63(3):237-47. PubMed ID: 14989713
[TBL] [Abstract][Full Text] [Related]
12. The HLA-DR2 haplotype is associated with an increased proliferative response to the immunodominant CD4(+) T-cell epitope in human interferon-beta.
Stickler M; Valdes AM; Gebel W; Razo OJ; Faravashi N; Chin R; Rochanayon N; Harding FA
Genes Immun; 2004 Jan; 5(1):1-7. PubMed ID: 14735143
[TBL] [Abstract][Full Text] [Related]
13. Allelic combinations of immune-response genes associated with glatiramer acetate treatment response in Russian multiple sclerosis patients.
Tsareva EY; Kulakova OG; Boyko AN; Shchur SG; Lvovs D; Favorov AV; Gusev EI; Vandenbroeck K; Favorova OO
Pharmacogenomics; 2012 Jan; 13(1):43-53. PubMed ID: 22111603
[TBL] [Abstract][Full Text] [Related]
14. Epitope analysis of the collagen type V-specific T cell response in lung transplantation reveals an HLA-DRB1*15 bias in both recipient and donor.
Keller MR; Haynes LD; Jankowska-Gan E; Sullivan JA; Agashe VV; Burlingham SR; Burlingham WJ
PLoS One; 2013; 8(11):e79601. PubMed ID: 24265781
[TBL] [Abstract][Full Text] [Related]
15. Effect of HLA genotype or CTLA-4 polymorphism on cytokine response in healthy children.
Walldén J; Ilonen J; Roivainen M; Ludvigsson J; Vaarala O;
Scand J Immunol; 2008 Sep; 68(3):345-50. PubMed ID: 18782261
[TBL] [Abstract][Full Text] [Related]
16. Different distribution of HLA class II alleles in anti-topoisomerase I autoantibody responders between silicosis and systemic sclerosis patients, with a common distinct amino acid sequence in the HLA-DQB1 domain.
Ueki A; Isozaki Y; Tomokuni A; Ueki H; Kusaka M; Tanaka S; Otsuki T; Sakaguchi H; Hyodoh F
Immunobiology; 2001 Dec; 204(4):458-65. PubMed ID: 11776400
[TBL] [Abstract][Full Text] [Related]
17. Combination treatment of Glatiramer Acetate and Minocycline affects phenotype expression of blood monocyte-derived dendritic cells in Multiple Sclerosis patients.
Ruggieri M; Pica C; Lia A; Zimatore GB; Modesto M; Di Liddo E; Specchio LM; Livrea P; Trojano M; Avolio C
J Neuroimmunol; 2008 Jul; 197(2):140-6. PubMed ID: 18555539
[TBL] [Abstract][Full Text] [Related]
18. Negative association between type 1 diabetes and HLA DQB1*0602-DQA1*0102 is attenuated with age at onset. Swedish Childhood Diabetes Study Group.
Graham J; Kockum I; Sanjeevi CB; Landin-Olsson M; Nyström L; Sundkvist G; Arnqvist H; Blohmé G; Lithner F; Littorin B; Scherstén B; Wibell L; Ostman J; Lernmark A; Breslow N; Dahlquist G
Eur J Immunogenet; 1999; 26(2-3):117-27. PubMed ID: 10331157
[TBL] [Abstract][Full Text] [Related]
19. Pharmacogenetics of glatiramer acetate therapy for multiple sclerosis reveals drug-response markers.
Grossman I; Avidan N; Singer C; Goldstaub D; Hayardeny L; Eyal E; Ben-Asher E; Paperna T; Pe'er I; Lancet D; Beckmann JS; Miller A
Pharmacogenet Genomics; 2007 Aug; 17(8):657-66. PubMed ID: 17622942
[TBL] [Abstract][Full Text] [Related]
20. HLA-DRB5*0101 and -DRB1*1501 expression in the multiple sclerosis-associated HLA-DR15 haplotype.
Prat E; Tomaru U; Sabater L; Park DM; Granger R; Kruse N; Ohayon JM; Bettinotti MP; Martin R
J Neuroimmunol; 2005 Oct; 167(1-2):108-19. PubMed ID: 16111772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
